What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Winette T. A. van der Graaf mostly deals with Internal medicine, Oncology, Surgery, Cancer and Sarcoma.
His Internal medicine study incorporates themes from Gynecology and Immunology.
His Oncology research is multidisciplinary, incorporating perspectives in Survival rate, Pathology, GiST, Breast cancer and Colorectal cancer.
Surgery is often connected to Urology in his work.
The various areas that he examines in his Cancer study include Anxiety, Compulsive behavior and Risk factor.
His work focuses on many connections between Sarcoma and other disciplines, such as Soft tissue, that overlap with his field of interest in Immunohistochemistry, Chemotherapy and Sunitinib malate.
His most cited work include:
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial (1193 citations)
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial (531 citations)
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (297 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Oncology, Sarcoma, Cancer and Soft tissue sarcoma.
His Internal medicine study frequently draws connections between related disciplines such as Surgery.
His Surgery study combines topics in areas such as Adverse effect and Urology.
His Oncology study which covers Cisplatin that intersects with Head and neck cancer and Chemoradiotherapy.
His studies deal with areas such as Soft tissue and MEDLINE as well as Sarcoma.
The concepts of his Cancer study are interwoven with issues in Young adult, Quality of life, Incidence and Psychosocial.
He most often published in these fields:
- Internal medicine (51.76%)
- Oncology (33.60%)
- Sarcoma (36.04%)
What were the highlights of his more recent work (between 2019-2021)?
- Sarcoma (36.04%)
- Internal medicine (51.76%)
- Cancer (30.62%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Sarcoma, Internal medicine, Cancer, Quality of life and Disease.
His Sarcoma research includes themes of Survivorship curve, Pediatrics and Stage.
His research brings together the fields of Oncology and Internal medicine.
His biological study spans a wide range of topics, including Young adult, Distress, Clinical trial and Incidence.
He works mostly in the field of Quality of life, limiting it down to concerns involving Cohort study and, occasionally, Observational study.
His work deals with themes such as MEDLINE and Family medicine, which intersect with Disease.
Between 2019 and 2021, his most popular works were:
- The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients (48 citations)
- A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours. (17 citations)
- The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry. (16 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Winette T. A. van der Graaf focuses on Sarcoma, Internal medicine, Quality of life, Cancer registry and Pharmacokinetics.
The study incorporates disciplines such as Stage, Disease, Soft tissue and MEDLINE in addition to Sarcoma.
He has included themes like Distress and Oncology in his Internal medicine study.
His Oncology research focuses on Cohort study and how it connects with Chemotherapy.
His Quality of life study combines topics from a wide range of disciplines, such as Soft tissue sarcoma, Cancer and Family medicine, Referral.
His Pharmacokinetics study also includes
- Sunitinib that intertwine with fields like Toxicity, Urology and Progression-free survival,
- Clinical trial most often made with reference to Tyrosine-kinase inhibitor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
